Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy

D. Sánchez, P. Gregor, K. Čurila, I. Hoffmanová, V. Hábová, L. Tučková, H. Tlaskalová-Hogenová,

. 2016 ; 49 (8) : 554-562. [pub] 20160930

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18017015

Distinct cellular level of the Ca2+-binding chaperone calreticulin (CRT) is essential for correct embryonal cardiac development and postnatal function. However, CRT is also a potential autoantigen eliciting formation of antibodies (Ab), whose role is not yet clarified. Immunization with CRT leads to cardiac injury, while overexpression of CRT in cardiomyocytes induces dilated cardiomyopathy (DCM) in animals. Hence, we analysed levels of anti-CRT Ab and calreticulin in the sera of patients with idiopatic DCM and hypertrophic cardiomyopathy (HCM). ELISA and immunoblot using human recombinant CRT and Pepscan with synthetic, overlapping decapeptides of CRT were used to detect anti-CRT Ab. Serum CRT concentration was tested by ELISA. Significantly increased levels of anti-CRT Ab of isotypes IgA (p < 0.001) and IgG (p < 0.05) were found in patients with both DCM (12/34 seropositive for IgA, 7/34 for IgG) and HCM (13/38 seropositive for IgA, 11/38 for IgG) against healthy controls (2/79 for IgA, 1/79 for IgG). Titration analysis in seropositive DCM and HCM patients documented anti-CRT Ab detected at 1/1600 dilution for IgG and 1/800 for IgA (and IgA1) and at least at 1/200 dilution for IgA2, IgG1, IgG2 and IgG3. Pepscan identified immunogenic CRT epitopes recognized by IgA and IgG Ab of these patients. Significantly increased levels of CRT relative to healthy controls were found in sera of patients with HCM (p < 0.01, 5/19). These data extend the knowledge of seroprevalence of anti-CRT Ab and CRT, and suggest possible involvement of autoimmune mechanisms directed to CRT in some forms of cardiomyopathies, which are clinically heterogeneous.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017015
003      
CZ-PrNML
005      
20180515103325.0
007      
ta
008      
180515s2016 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/08916934.2016.1214822 $2 doi
035    __
$a (PubMed)27689957
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Sánchez, Daniel $u a Laboratory of Cellular and Molecular Immunology , Institute of Microbiology v.v.i, Czech Academy of Sciences , Prague , Czech Republic.
245    10
$a Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy / $c D. Sánchez, P. Gregor, K. Čurila, I. Hoffmanová, V. Hábová, L. Tučková, H. Tlaskalová-Hogenová,
520    9_
$a Distinct cellular level of the Ca2+-binding chaperone calreticulin (CRT) is essential for correct embryonal cardiac development and postnatal function. However, CRT is also a potential autoantigen eliciting formation of antibodies (Ab), whose role is not yet clarified. Immunization with CRT leads to cardiac injury, while overexpression of CRT in cardiomyocytes induces dilated cardiomyopathy (DCM) in animals. Hence, we analysed levels of anti-CRT Ab and calreticulin in the sera of patients with idiopatic DCM and hypertrophic cardiomyopathy (HCM). ELISA and immunoblot using human recombinant CRT and Pepscan with synthetic, overlapping decapeptides of CRT were used to detect anti-CRT Ab. Serum CRT concentration was tested by ELISA. Significantly increased levels of anti-CRT Ab of isotypes IgA (p < 0.001) and IgG (p < 0.05) were found in patients with both DCM (12/34 seropositive for IgA, 7/34 for IgG) and HCM (13/38 seropositive for IgA, 11/38 for IgG) against healthy controls (2/79 for IgA, 1/79 for IgG). Titration analysis in seropositive DCM and HCM patients documented anti-CRT Ab detected at 1/1600 dilution for IgG and 1/800 for IgA (and IgA1) and at least at 1/200 dilution for IgA2, IgG1, IgG2 and IgG3. Pepscan identified immunogenic CRT epitopes recognized by IgA and IgG Ab of these patients. Significantly increased levels of CRT relative to healthy controls were found in sera of patients with HCM (p < 0.01, 5/19). These data extend the knowledge of seroprevalence of anti-CRT Ab and CRT, and suggest possible involvement of autoimmune mechanisms directed to CRT in some forms of cardiomyopathies, which are clinically heterogeneous.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a autoprotilátky $x krev $x imunologie $7 D001323
650    _2
$a autoantigeny $x krev $x imunologie $7 D001324
650    _2
$a autoimunita $7 D015551
650    _2
$a biologické markery $7 D015415
650    _2
$a kalretikulin $x krev $x imunologie $7 D037282
650    _2
$a dilatační kardiomyopatie $x krev $x diagnóza $x imunologie $7 D002311
650    _2
$a hypertrofická kardiomyopatie $x krev $x diagnóza $x imunologie $7 D002312
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ELISA $7 D004797
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunoglobulin A $x krev $x imunologie $7 D007070
650    _2
$a imunoglobulin G $x krev $x imunologie $7 D007074
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gregor, Pavel $u b Cardiocenter, Department of Cardiology, Third Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady , Prague , Czech Republic , and.
700    1_
$a Čurila, Karol $u b Cardiocenter, Department of Cardiology, Third Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady , Prague , Czech Republic , and.
700    1_
$a Hoffmanová, Iva $u c Second Department of Internal Medicine, Third Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady , Prague , Czech Republic.
700    1_
$a Hábová, Věra $u a Laboratory of Cellular and Molecular Immunology , Institute of Microbiology v.v.i, Czech Academy of Sciences , Prague , Czech Republic.
700    1_
$a Tučková, Ludmila $u a Laboratory of Cellular and Molecular Immunology , Institute of Microbiology v.v.i, Czech Academy of Sciences , Prague , Czech Republic.
700    1_
$a Tlaskalová-Hogenová, Helena $u a Laboratory of Cellular and Molecular Immunology , Institute of Microbiology v.v.i, Czech Academy of Sciences , Prague , Czech Republic.
773    0_
$w MED00000637 $t Autoimmunity $x 1607-842X $g Roč. 49, č. 8 (2016), s. 554-562
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27689957 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103458 $b ABA008
999    __
$a ok $b bmc $g 1300639 $s 1013855
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 49 $c 8 $d 554-562 $e 20160930 $i 1607-842X $m Autoimmunity $n Autoimmunity $x MED00000637
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...